Your browser doesn't support javascript.
loading
Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
Lucci, Anthony; Hall, Carolyn S; Patel, Sapna P; Narendran, Boomadevi; Bauldry, Jessica B; Royal, Richard E; Karhade, Mandar; Upshaw, Joshua R; Wargo, Jennifer A; Glitza, Isabella C; Wong, Michael K K; Amaria, Rodabe N; Tawbi, Hussein A; Diab, Adi; Davies, Michael A; Gershenwald, Jeffrey E; Lee, Jeffrey E; Hwu, Patrick; Ross, Merrick I.
Afiliación
  • Lucci A; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. alucci@mdanderson.org.
  • Hall CS; Department of Breast Surgery-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Narendran B; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bauldry JB; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Royal RE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Karhade M; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Upshaw JR; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Glitza IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wong MKK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 26(8): 1886-1895, 2020 04 15.
Article en En | MEDLINE | ID: mdl-32015020
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Ganglios Linfáticos / Melanoma / Células Neoplásicas Circulantes / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Biomarcadores de Tumor / Ganglios Linfáticos / Melanoma / Células Neoplásicas Circulantes / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article